MSH2 and Lynch syndrome: Of the remaining 20% of CRC tumours that do not carry APC mutations, many of these are associated with mutation of DNA mismatch repair (MMR) genes or inactivation predominantly of the mismatch repair genes MLH1 and MSH2 (Lynch syndrome) 15, 16, 17.